Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19

Allergy
Aslı GelincikMaria Jose Torres

Abstract

Coronavirus disease 2019 (COVID-19), a respiratory tract infection caused by a novel human coronavirus, the severe acute respiratory syndrome coronavirus 2, leads to a wide spectrum of clinical manifestations ranging from asymptomatic cases to patients with mild and severe symptoms, with or without pneumonia. Given the huge influence caused by the overwhelming COVID-19 pandemic affecting over three million people worldwide, a wide spectrum of drugs is considered for the treatment in the concept of repurposing and off-label use. There is no knowledge about the diagnosis and clinical management of the drug hypersensitivity reactions that can potentially occur during the disease. This review brings together all the published information about the diagnosis and management of drug hypersensitivity reactions due to current and candidate off-label drugs and highlights relevant recommendations. Furthermore, it gathers all the dermatologic manifestations reported during the disease for guiding the clinicians to establish a better differential diagnosis of drug hypersensitivity reactions in the course of the disease.

References

Jun 4, 1988·British Medical Journal·P A Phillips-Howard, J Warwick Buckler
Nov 1, 1994·The American Journal of Medicine·P WeinmannF Leynadier
Apr 1, 1994·Allergy·G PatriarcaR Schiavello
Jan 1, 1996·Dermatology : International Journal for Clinical and Investigative Dermatology·K MochidaT Hamada
Mar 12, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·G W Volcheck, R G Van Dellen
Feb 13, 1999·The New England Journal of Medicine·S AngelidesS B Freedman
Sep 29, 1999·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·H MeierB Wüthrich
May 29, 2001·Neurology·D L BrownP L Powers
Aug 8, 2001·Clinical and Experimental Dermatology·M Murphy, A J Carmichael
Sep 26, 2001·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·D G EboW J Stevens
Feb 12, 2002·European Journal of Internal Medicine·Gise'le KannyD Anne Moneret-Vautrin
Jun 28, 2002·The Annals of Pharmacotherapy·Amanda H CorbettAngela D M Kashuba
Apr 23, 2003·Journal of the European Academy of Dermatology and Venereology : JEADV·J M de Sousa PintoT Estanislau Correia
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·I BankH R Büller
Aug 13, 2003·Allergy·W AbererUNKNOWN EAACI interest group on drug hypersensitivity
Aug 23, 2003·Seminars in Liver Disease·Kimberly A PowersAlan S Perelson
Sep 19, 2003·The Journal of Allergy and Clinical Immunology·Raquel EmpedradRebecca S Gruchalla
Sep 27, 2003·The British Journal of Dermatology·K KerlJ Lübbe
Sep 27, 2003·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S MellerB Homey
Dec 13, 2003·Allergologia et immunopathologia·M R Caballero, M Fernández-Benítez
Jun 10, 2004·Contact Dermatitis·Paolo LisiKatharina Hansel
Jun 23, 2004·Acta Dermato-venereologica·Francesca CottoniAntonio Solinas
Dec 21, 2004·Biochemical and Biophysical Research Communications·Birgit MorgensternJindrich Cinatl
Jan 25, 2005·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Y BerkunM Shalit
Aug 17, 2005·Journal of Virology·Cori L Fata-Hartley, Ann C Palmenberg
Oct 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jade GhosnEric Caumes
Nov 1, 2005·The Journal of Thoracic and Cardiovascular Surgery·Kalpaj ParekhBarbara A Muller
Nov 18, 2005·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Piotr MilkiewiczJenny Heathcote
Sep 13, 2006·Allergologia et immunopathologia·P Rojas Pérez-EzquerraA Prieto García
Oct 5, 2006·Current Pharmaceutical Design·M T VenturaA Romano
Jan 25, 2007·Contact Dermatitis·Sanja Milković-KrausBozica Kanceljak-Macan
Jul 11, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jean-Michel MolinaUNKNOWN TMC114-C215 Study Group
Oct 24, 2007·Clinical Rheumatology·Alessandro VolpeGuido Arcaro
Jul 22, 2008·Journal of the American Academy of Dermatology·Michael ConroyTammie Ferringer
Nov 11, 2008·Current Pharmaceutical Design·Luis Araújo, Pascal Demoly
Dec 17, 2008·Annales de dermatologie et de vénéréologie·J-L SchmutzP Tréchot
Jan 8, 2009·International Archives of Allergy and Immunology·Ayse Fusun KalpakliogluAli Kemal Erdemoglu
Feb 5, 2009·Annals of Internal Medicine·Amit PursnaniNitasha Sarswat

❮ Previous
Next ❯

Citations

Jun 15, 2020·Allergy·Carmen RiggioniCezmi A Akdis
Dec 31, 2020·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Dirk TomsitzKnut Brockow
Feb 10, 2021·Current Allergy and Asthma Reports·Adriana Izquierdo-DomínguezIsam Alobid
Feb 9, 2021·The World Allergy Organization Journal·Luciana Kase TannoMarco Caminati
Aug 12, 2020·Allergy·Maria J Torres
May 22, 2021·Immunopharmacology and Immunotoxicology·Ahmad Reza FarmaniNima Rezaei
May 25, 2021·Clinical Case Reports·Saeedeh Farajzadeh, Najmeh Ahramiyanpour
Jul 10, 2021·Journal of Medical Virology·Zeinab Mohseni AfsharSoheil Ebrahimpour

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.